Microglia: proliferation and activation driven by the P2X7 receptor.
暂无分享,去创建一个
[1] J. Lucas,et al. Altered P2X7‐receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] C. Reid,et al. The P2X7 Receptor Drives Microglial Activation and Proliferation: A Trophic Role for P2X7R Pore , 2009, The Journal of Neuroscience.
[3] F. Conquet,et al. Up-Regulation of P2X4 Receptors in Spinal Microglia after Peripheral Nerve Injury Mediates BDNF Release and Neuropathic Pain , 2008, The Journal of Neuroscience.
[4] H. Le Stunff,et al. P2X7 receptor-mediated phosphatidic acid production delays ATP-induced pore opening and cytolysis of RAW 264.7 macrophages. , 2007, Cellular signalling.
[5] Hyun B Choi,et al. Modulation of the Purinergic P2X7 Receptor Attenuates Lipopolysaccharide-Mediated Microglial Activation and Neuronal Damage in Inflamed Brain , 2007, The Journal of Neuroscience.
[6] K. Jacobson,et al. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis , 2007, Nature.
[7] W. Gan,et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides , 2006, Nature Neuroscience.
[8] F. Di Virgilio,et al. A role for P2X7 in microglial proliferation , 2006, Journal of neurochemistry.
[9] Hyun B Choi,et al. Upregulated Expression of Purinergic P2X7 Receptor in Alzheimer Disease and Amyloid-&bgr; Peptide-Treated Microglia and in Peptide-Injected Rat Hippocampus , 2006, Journal of neuropathology and experimental neurology.
[10] T. Joh,et al. Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease , 2006, Experimental & Molecular Medicine.
[11] P. Anand,et al. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord , 2006, BMC neurology.
[12] G. Burnstock,et al. Microglial morphology and its transformation after challenge by extracellular ATP in vitro , 2006, Journal of neuroscience research.
[13] F. Helmchen,et al. Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo , 2005, Science.
[14] Kazuhide Inoue,et al. Production and Release of Neuroprotective Tumor Necrosis Factor by P2X7 Receptor-Activated Microglia , 2004, The Journal of Neuroscience.
[15] S. Koizumi,et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury , 2003, Nature.
[16] H. Korf,et al. The bisphosphonate clodronate depletes microglial cells in excitotoxically injured organotypic hippocampal slice cultures , 2003, Experimental Neurology.
[17] B. Robertson,et al. P2X7 Mediates Superoxide Production in Primary Microglia and Is Up-regulated in a Transgenic Mouse Model of Alzheimer's Disease* , 2003, The Journal of Biological Chemistry.
[18] W. Dietrich,et al. Inflammatory Mechanisms after Ischemia and Stroke , 2003, Journal of neuropathology and experimental neurology.
[19] G. Garden. Microglia in human immunodeficiency virus‐associated neurodegeneration , 2002, Glia.
[20] E. Cavalheiro,et al. Evidence That ATP Participates in the Pathophysiology of Pilocarpine‐Induced Temporal Lobe Epilepsy: A Fluorimetric, Immunohistochemical, and Western Blot Studies , 2002, Epilepsia.
[21] A. Hao,et al. Origin of microglia , 2001, Microscopy research and technique.
[22] A. Reichenbach,et al. Upregulation of P2X(7) receptor currents in Müller glial cells during proliferative vitreoretinopathy. , 2001, Investigative ophthalmology & visual science.
[23] F. Di Virgilio,et al. Increased Proliferation Rate of Lymphoid Cells Transfected with the P2X7 ATP Receptor* , 1999, The Journal of Biological Chemistry.
[24] Hua Yu,et al. Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis , 1999, Journal of Neuroimmunology.
[25] M. Gurney,et al. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS , 1998 .
[26] F. Virgilio. ATP as a death factor , 1998, BioFactors.
[27] E. Kawashima,et al. Tissue distribution of the P2X7 receptor , 1997, Neuropharmacology.
[28] D. Ferrari,et al. Spontaneous Cell Fusion in Macrophage Cultures Expressing High Levels of the P2Z/P2X7 Receptor , 1997, The Journal of cell biology.
[29] Stefania Hanau,et al. Purinergic Modulation of Interleukin-1  Release from Microglial Cells Stimulated with Bacterial Endotoxin Materials and Methods , 1997 .
[30] E. Kawashima,et al. The Cytolytic P2Z Receptor for Extracellular ATP Identified as a P2X Receptor (P2X7) , 1996, Science.
[31] I. Black,et al. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[32] I. Schieren,et al. P2Z adenosine triphosphate receptor activity in cultured human monocyte-derived macrophages. , 1994, Blood.
[33] K. Williams,et al. Induction of primary T cell responses by human glial cells , 1993, Journal of neuroscience research.
[34] W. Streit,et al. A chronicle of microglial ontogeny , 1993, Glia.
[35] K. Boje,et al. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death , 1992, Brain Research.
[36] N. Takei,et al. Production of basic fibroblast growth factor in cultured rat brain microglia , 1991, Neuroscience Letters.
[37] J. Scholes,et al. Diversity amongst the microglia in growing and regenerating fish CNS: Immunohistochemical characterization using FL. 1, an anti‐macrophage monoclonal antibody , 1991, Glia.
[38] P. Mcgeer,et al. Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.
[39] V. Perry,et al. Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain , 1985, Neuroscience.